Stroke Management Market 2025 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2035
Page: 215 | Report Code: LS250801 | Research Suite: Report (PDF) & Market Data (Excel)
The global stroke management market was valued at USD 39.3 billion in 2024, and a CAGR of 11.1% is expected during the forecast period. The surge in the aging population, advancements in technology, and treatment are driving the growth of the market significantly. Technological advancements and numerous research institutes are driving the growth of the market significantly. The geriatric population worldwide is more susceptible to stroke. Lifestyle changes are leading to higher chances of strokes.
The global economic recession has moderately impacted the stroke management market. The rise in government initiatives is making people more aware of the treatments for such serious diseases. An increasing number of patients suffering from stress and anxiety are also more susceptible to stroke, and they are contributing to the growth of this market. According to the Centers for Disease Control and Prevention, 1 out of 6 deaths from cardiovascular diseases in the U.S.A. in 2021 was due to stroke. Every 40 seconds, someone in the United States is having a stroke.
Impact
of Covid-19
COVID-19 had a mixed impact on the stroke management
market. At the beginning, the shift in priority of medical centers all over the
world has badly hampered the market. Patients had to suffer a lot due to the
unavailability of doctors and the temporary shutdown of hospitals for non-covid
patients. But later on, with the passage of time, things started to work in
favor of the market when online consultation started. Telemedicine gained
traction for consultations, but delayed treatments and reduced hospital visits
affected timely interventions. Cases of stroke increased drastically during
COVID-19. People were completely packed inside the home. People were mentally very
puzzled during COVID-19; rising blood pressure and cholesterol were the main
causes of the pandemic behind the stroke.
Growth
Drivers
·
Advancements in Technology
·
Increasing prevalence of Stroke
·
Rising Geriatric Population
·
Development of innovative treatments
and therapies
·
Awareness Campaigns and Governments
Initiatives
Advancements in technology in stroke management include telemedicine and tele stroke services. These enable remote consultations with top-class doctors and quicker diagnoses, especially for patients who live in rural areas. Innovations in CT-Scan, MRI, and angiography provide more precise and timely diagnosis, allowing for better-informed treatment plans. Techniques like endovascular thrombectomy and embolization offer less invasive treatment. Robotic devices aid in stroke rehabilitation, providing personalized therapy to improve motor skills and functional abilities. Wearable devices and monitoring systems, as well as AI and machine learning, assist in analyzing vast amounts of data.
Factors such as weakened blood vessels, a higher prevalence of conditions like diabetes and hypertension, and heart diseases contribute to an increased susceptibility to strokes among older adults. Obesity, high blood pressure, high cholesterol, smoking, and an excess amount of alcohol are the things that lead a person towards stroke. Life in countries with dense populations like India is even more challenging due to the large population and fewer opportunities, resulting in a large number of stressed patients who are more stroke-prone. Awareness campaigns and government initiatives play a vital role in stroke management. Various NGOs are working in this direction in rural areas to make people more aware of health issues. The government is also much more alert to deal with these issues.
Segmentation
Type
·
Diagnostics
·
Therapeutics
·
Software
·
Brain Aneurysm
·
Hemorrhagic strokes
·
Ischemic Strokes
·
Transient Ischemic Attack
End-Users
·
Hospitals
·
Specialty Clinics
·
ASCs Clinics
Regional
Outlook
·
Asia Pacific
·
North America
·
Latin America
·
Europe
·
Middle East and Africa
Stroke
Management Market Type Segmentation
On the basis of type, the stroke management market is
segmented into diagnostics, therapeutics, software, brain aneurysm, hemorrhagic
strokes, ischemic strokes, and transient ischemic attack. The diagnostics
segment is the leading one and is expected to dominate during the forecast
period. MRI, SCANS, and various other tests can easily tell about the risk of
stroke. Early diagnosis is the most important segment, for which laboratories
and research centers are established. Therapeutics is expected to dominate
during the forecast period. Ischemic strokes are the most common. Ischemic
strokes are in 87% of strokes, in which the blood flow to the brain is
prohibited. The software segment is expected to grow at the fastest pace during
the forecast period due to the development of advanced software in order to
diagnose and treat brain strokes.
Stroke
Management Market End-Users Segmentation
On the basis of end-users, the stroke management market is
segmented into hospitals, specialty clinics, and AC clinics. Hospitals are the
leading segment and are expected to maintain their dominance during the
forecast period. Specialty clinics are established to provide a better cure for
stroke patients. The recognition of Artemis Hospital’s SVIN Unit is the best
one for improving stroke care all around the world. The increasing attention of
governments all over the world is also driving this market towards positive
growth, and government hospitals with modern facilities are also not far
behind.
Regional
Outlook
On the basis of the region, the stroke management market is segmented into: Asia Pacific, North America, Europe, the Middle East and Africa, and Latin America. Due to advanced healthcare systems, extensive research systems, and robust technological adoption, North America is the leading region in the stroke management market. Similar to North America, Europe invests in advanced healthcare technologies and has a well-established stroke management protocol. Due to the large population and changing lifestyles, the threat of stroke is greater in countries like China and India. Advancement in healthcare infrastructure and increasing awareness are driving the growth of the market in these countries. The presence of big market players like Pfizer and Abbott is driving growth in the North American market.
Due to poor healthcare infrastructure, Latin America has to
face challenges. The Middle East is showing some growth due to the presence of
big markets like the U.A.E. Brazil, Saudi Arabia, and South Africa are also
showing some growth during the forecast period.
Key
Players
·
Boston Scientific Corporation
·
Abbott Laboratories
·
Bristol Myers Squibb Company
·
Cardinal Health
·
General Electric Company
·
Medtronics
·
Siemens AG
·
Aidoc
·
Brainomix
·
Vassol Inc
·
Other Players